Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy

Effects of Angiotensin Receptor Blocker on Phenotypic Alterations of Podocytes in Early Diabetic Nephropathy

(2011) Hou-Yong Dai et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss

(2010) Gang Wang et al.   RENAL FAILURE

Epithelial-Mesenchymal Transition and Podocyte Loss in Diabetic Kidney Disease

(2009) Kimberly Reidy et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic Nephropathy

(2009) Yukinari Yamaguchi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms’ tumor-1 protein used as a podocyte marker

(2009) Jian Su et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Hypertrophy and Loss of Podocytes in Diabetic Nephropathy

(2009) Masaaki Miyauchi et al.   INTERNAL MEDICINE

Urine Podocyte mRNAs Mark Progression of Renal Disease

(2009) Y. Sato et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Role of Podocalyxin in Health and Disease

(2009) J. S. Nielsen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy

(2008) G. Wang et al.   DIABETOLOGIA